Dublin, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/x53tf3/closed_drug)
has announced the addition of the "Closed
Drug Transfer Systems. Therapeutic Markets, Strategies and
Outlook" report to their offering.
The administration of drugs deemed hazardous to humans has been
receiving increasing amounts of scrutiny in recent years as the
dangers of these substances become more clearly understood. For
caregivers and their patients, the therapeutic area that is at the
forefront of attempts to mitigate exposure to cytotoxic drugs is
clinical oncology, a field that - in spite of promising new drugs
based on therapeutic antibodies - continues to rely heavily on
antineoplastics, a class that includes alkylating agents and
antimetabolites, to treat a wide range of cancers. Regulatory and
industry efforts to create standards and procedures designed to
protect workers and patients from accidental and incidental
exposure to cytotoxics are being driven by data that suggests a
causal link between exposure and health issues. Studies of nurses
who work with cytotoxic
drugs on a regular basis have found a statistically higher rate
of spontaneous abortion. Several companies are responding to this
unmet need by commercializing devices for closed transfer of these
drugs. As the market evolves and user acceptance increases, so too
will the impact of these products on oncology therapy protocols and
drug delivery.
Highlights
- Analyzes the impact of drug toxicity and safety factors on therapeutic oncology market segments, market dynamics and market demographics
- Provides detailed analysis of closed drug transfer products for the handing of cytotoxic drugs
- Analyzes demand drivers and competitive factors influencing closed drug transfer adoption
- Charts product data and provides forecasts to 2017
- Profiles closed drug transfer device participants, their product development activities, business strategies, and corporate alliances and affiliations
Topics Covered
Executive Summary
Oncology Therapeutics Market Dynamics
- Therapeutic Trends and Issues
- The Administration of injectable/Infusable Antineoplastics
- Drug Packaging and Administration Technology
- Closed Drug Transfer Market Drivers
- Competitive Landscape
- Risk Factors
Closed Drug Transfer Design Factors
- Key System Design Elements
- Human Engineering/Ergonomics
- Material Selection Issues
- Drug Reconstitution and Dilution
- Oncology Therapeutics Medication Safety
- Oncology Drug Administration and Dosing
- Drug-Specific Dosing Modification and Individualized Dosing
Closed Drug Transfer - Commercial Device Assessments and Market
Data
Market Factors
Regulatory Issues
- Caregiver Compliance
- Level of Complexity and Ease of Use
- Healthcare Economics
- Business Models and Strategies
Market Assessments and Forecasts
- North America
- Europe
- Asia
- Other Geographic Markets
Closed Drug Transfer - Market Participant Profiles
For more information visit http://www.researchandmarkets.com/research/x53tf3/closed_drug
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Drug Delivery